# BOEHRINGER INGELHEIM PROMECO S.A. de C.V. – FDA Inspection, May 20, 2022

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-promeco-sa-de-cv/e3f1b968-b78b-43ea-9213-e9465ed15259
Source feed: FDA_Inspections

> FDA inspection 1170081 of BOEHRINGER INGELHEIM PROMECO S.A. de C.V., May 20, 2022. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1170081
- Company Name: BOEHRINGER INGELHEIM PROMECO S.A. de C.V.
- Inspection Date: 2022-05-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1303242 - 2024-02-09
- [FDA Inspection 1115474 - 2019-12-06](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-promeco-sa-de-cv/39023c5b-17e3-4c8c-97f2-c5803f1f32f0)
- FDA Inspection 1040046 - 2017-12-08
- FDA Inspection 955438 - 2015-11-20
- FDA Inspection 841397 - 2013-06-25

Company: https://www.keypedia.com/companies/boehringer-ingelheim-promeco-sa-de-cv/d1f077c2-d2d3-4a71-b897-7595adbb343b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
